Related Experiment Video
Updated: Aug 19, 2026

Kupffer Cell Isolation for Nanoparticle Toxicity Testing
Published on: August 18, 2015
Biocompatibility of micro- and nanoparticles. Part I: in liver and kidney
Antonietta M Gatti1, Francesco Rivasi
1Istituto Nazionale Fisica della Materia, Department of Surgery, University of Modena and Reggio Emilia, Italy. gatti@unimo.it
Abstract:
An accidental discovery led us to correlate a pathology of "unknown origin" with the presence of micro- and nano-particles of inorganic nature in the human tissues. Bioptic samples of livers and kidneys affected by cryptogenic granulomas were observed through a new type of electron scanning microscope called environmental scanning electron microscope and X-ray-microanalyzed with an energy dispersive system. All the randomly selected samples showed the presence of inorganic samples, sometimes varying in chemical composition, but consistent in size (larger in the liver, smaller in the kidney). This article illustrates the results obtained on randomly picked samples and proposes our new investigative method as an aid to achieve a medical diagnosis. Two more items are discussed: the possible, until now unexplained, origin of a pathology as deriving from the presence of exogenous particles, so a new word "nano-pathology" was developed and, as a consequence, the relativity of the concept of biocompatibility as depending on the size of the material considered and its local concentration. The implications of the discovery are briefly discussed.
Related Concept Videos
Drug Distribution: Tissue Binding
For...
Drug Biotransformation: Overview
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Kidney Transplant I: Introduction

